News Focus
News Focus
icon url

jbog

02/10/14 5:48 PM

#11154 RE: jmkobers #11151

Even though Mylan filed 1 1/2 years later that still means the FDA has had close to 4 years to review it.

Besides, Mylan should have substantial clinical and real life data it could submit because their drug (natco) has been in use for years.
icon url

alertmeipp

02/10/14 7:03 PM

#11157 RE: jmkobers #11151

the same happened to mL, it was range bounded until the approval hit. It was well telegraphed that it will come soon. You know some investors don't want to wait indefinitely even those the indefinitely would mean soon.